Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariaemma Rodegher

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2019
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple SclerosisPaolo Preziosa, Maria A Rocca, Gianna C Riccitelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2017
Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosisMilagros Hidalgo de la Cruz, Alessandro d'Ambrosio, Paola Valsasina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 16, 2017
Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairmentMaria A Rocca, Paola Valsasina, Victoria M Leavitt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 13, 2026
Event-related potentials and behavioural correlates of cognitive functions in MS: An EEG study during symbol digit modalities testMarta Tacchini, Giulia Gamberini, Michelangelo Dini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 9, 2020
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimodAlessandro d'Ambrosio, Rocco Capuano, Settimio Rossi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2014
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?Giovanni Di Maggio, Roberto Santangelo, Simone Guerrieri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2015
Myeloid cells as target of fingolimod action in multiple sclerosisMarco Di Dario, Emanuela Colombo, Chiara Govi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2015
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric studyLaura Ferrè, Arturo Nuara, Giulia Pavan, et al.
Journal of Neuroimmunology|December 1, 2010
MGAT5 and disease severity in progressive multiple sclerosisFederica Esposito, Jerome Wojcik, Mariaemma Rodegher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease predictionFederica Esposito, Clara Guaschino, Melissa Sorosina, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2019
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple SclerosisPaolo Preziosa, Maria A Rocca, Gianna C Riccitelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2017
Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosisMilagros Hidalgo de la Cruz, Alessandro d'Ambrosio, Paola Valsasina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 16, 2017
Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairmentMaria A Rocca, Paola Valsasina, Victoria M Leavitt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 13, 2026
Event-related potentials and behavioural correlates of cognitive functions in MS: An EEG study during symbol digit modalities testMarta Tacchini, Giulia Gamberini, Michelangelo Dini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 9, 2020
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimodAlessandro d'Ambrosio, Rocco Capuano, Settimio Rossi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2014
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?Giovanni Di Maggio, Roberto Santangelo, Simone Guerrieri, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2015
Myeloid cells as target of fingolimod action in multiple sclerosisMarco Di Dario, Emanuela Colombo, Chiara Govi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2015
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric studyLaura Ferrè, Arturo Nuara, Giulia Pavan, et al.
Journal of Neuroimmunology|December 1, 2010
MGAT5 and disease severity in progressive multiple sclerosisFederica Esposito, Jerome Wojcik, Mariaemma Rodegher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease predictionFederica Esposito, Clara Guaschino, Melissa Sorosina, et al.
Pageof 6